1. OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, AND CAR T CELL THERAPY IN TP53 ALTERED MANTLE CELL LYMPHOMA: A MULTI‐INSTITUTION RETROSPECTIVE ANALYSIS
- Author
-
Messmer, M., primary, Stack, A., additional, Deng, M., additional, Handorf, E., additional, Kapoor, N., additional, Sawalha, Y., additional, Bock, A. M., additional, Wang, Y., additional, Graf, K., additional, Greenwell, B., additional, Cleveland, J., additional, Advani, R., additional, Herrera, D. Adrianzen, additional, Cai, E., additional, Spinner, M., additional, Hassan, A., additional, Rajguru, S., additional, Phillips, M. S., additional, Smith, S. D., additional, Brooks, T., additional, Bond, D., additional, Hill, B., additional, Murphy, J., additional, Wagner‐Johnston, N., additional, Zahid, M., additional, Awan, F. T., additional, Geethakumari, P. Ramakrishnan, additional, Tompkins, W., additional, Deshpande, S., additional, Svoboda, J., additional, Ryu, C., additional, Amengual, J., additional, Anna, J., additional, Kamdar, M., additional, Goparaju, K., additional, Martin, J., additional, Burkart, M., additional, Karmali, R., additional, Khan, A., additional, Modi, D., additional, Nickel, M., additional, Hambley, B., additional, Baron, K., additional, Shah, H., additional, Wallace, D., additional, Friedberg, J. W., additional, Hannah, C., additional, Bachanova, V., additional, Ghosh, N., additional, Park, S., additional, David, K., additional, Darrah, J., additional, Fisher, R. I., additional, and Khan, N., additional
- Published
- 2023
- Full Text
- View/download PDF